VERX Vertex, Inc. Insider Trading

10% Owner of Vertex (VERX) purchases 10,000 shares at $15.05; stock down 64.3% from 52-week high and -23.8% over 90 days.

A 10% owner (ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL) acquired 10,000 shares on 2026-03-09 at $15.05, bringing total holdings to 1,221,100 shares. This contrasts sharply with the insider's documented prior behavior at this ticker: in five prior transactions, all were sells, and all five exhibited negative 90-day returns, indicating well-timed exits before declines. The current purchase occurs as VERX trades at $14.94 (below transaction price) and is -64.3% from its 52-week high, with the stock declining -23.8% over 90 days. The insider's same-ticker history at VERX shows a consistent pattern of selling into strength (100% of prior trades were sells, all well-timed by 90-day performance). This buy—the first recorded purchase—may signal a tactical view, but must be weighed against the broader context: elevated valuation (P/E of 62.25), modest profitability ($4.0M net income on $192.1M revenue), and a price trajectory that is substantially below the insider's prior sell windows.

CEO Christopher David buys 60,000 shares of VERX at $12.18; stock -70.5% from 52-week high, cluster buy with 2 other insiders in 14 days

Christopher David, President and CEO, purchased 60,000 shares at $12.18 on 2026-02-23, representing his first open-market position at the company. The purchase occurs against a backdrop of significant price deterioration: the stock has fallen 70.5% from its 52-week high of $45.44 and is down 32.4% over the past 30 days. The timing coincides with a cluster buy pattern, with 2 other insiders also acquiring shares within the past 14 days, suggesting coordinated action across the leadership group. While the company shows positive fundamentals (revenue growth of 12.2% year-over-year, $192.1M quarterly revenue), the elevated P/E of 55.79 against current profitability ($4.0M net income) and the sharp recent price declines warrant attention to what prompted the synchronized buying at current levels.

Director Eric Andersen buys 40,000 VERX shares at $12.91 as stock down -74.7% from 52-week high; cluster buy emerges

Director Eric Andersen purchased 40,000 shares at $12.91 on 2026-02-20, increasing his holdings by 36.3% to 150.3K shares. The buy occurred after VERX stock fell -74.7% from its 52-week high of $47.62 and declined -38.9% over the prior 30 days. Notably, the company remains unprofitable on a full-year basis despite posting $192.1M in quarterly revenue and 16.5% annual growth, creating tension between growth metrics and profitability. A cluster pattern has emerged with 2 other insiders also buying within the past 14 days, though Andersen's own prior track record at this ticker shows 0 of 2 prior sales were well-timed (both subsequent 90-day returns were positive, indicating he sold before gains materialized), limiting confidence in the signal's predictive value.

Westphal buys 397.7K VERX shares for $5.1M at blended $12.88 as stock falls -74.6% from 52-week high

Westphal acquired 397,740 shares across two transactions on 2026-02-13 and 2026-02-17 for a blended average price of $12.88, totaling $5,121,293.55. The purchase occurs as VERX trades at $12.09, down 74.6% from its 52-week high of $47.62 and down 37.4% over the past 30 days. Fundamentally, the company generated $192.1M in quarterly revenue with +16.5% annual growth but remained unprofitable on a full-year basis, with net income of negative at the fiscal level. Westphal's track record at VERX is mixed: his prior 5 trades at this ticker included 4 sales, 4 of which were well-timed at the 90-day mark (stock fell after the sale), suggesting prior skill in exiting before downturns. The scale of this new purchase—397.7K shares from a zero base—represents a material commitment at depressed price levels, though the timing occurs amid significant recent deterioration in the stock's momentum.

10% owner Jeffrey R. Westphal trust sold 381,233 shares for $13.9M over 3 days (June 16-18, 2025) at $36.59 avg, reducing holdings by 65.9%

A trust account controlled by 10% owner Jeffrey R. Westphal executed three separate sales totaling 381,233 shares for $13,949,825.78 between June 16–18, 2025, reducing holdings from 578,073 to 196,840 shares—a 65.9% reduction. The blended average sale price was $36.59, while the stock now trades at $35.52, down 39.8% from its 52-week high of $58.95 and down 7.8% over the past 30 days. Across his prior VERX-specific trades (5 prior sells), the insider's timing has been consistently poor at the 90-day mark—none of those prior sales were well-timed, as the stock rose after each. The company reported revenue of $177,062,000.00 in the latest quarter with positive net income of $11,130,000.00, but was unprofitable over the most recent full fiscal year. This large, consecutive three-day disposition by a major shareholder at prices materially above current levels warrants scrutiny of the insider's conviction and the timing relative to subsequent market deterioration.

Westphal sells 3,000,000 VERX shares for $115,350,000.00; prior same-ticker sells mostly profitable at 90d.

Westphal executed 3 separate sales totaling 3,000,000 shares for $115,350,000.00 at $38.45 on 2025-06-09, reducing holdings to zero in Table I common shares. This is a large single-day liquidation of a concentrated position. The Flag indicates this represents a derivative-conversion transaction, meaning the insider's actual economic exposure may extend beyond Table I common shares and warrants review of derivative holdings before concluding the position is fully wound down. Historically at VERX, his prior 5 sales show mixed timing: 4 of 5 generated positive 90-day returns after the sale (2024-11-11, 2024-10-03, 2024-07-23, 2024-06-05), meaning the stock subsequently rose—poorly-timed exits from an investor perspective. Only 1 of 5 (2024-12-12) produced a negative 90-day return (-35.9%), representing a well-timed sale before a decline. The current stock price of $37.55 stands -36.3% from its 52-week high, and the company posted a negative full-year net income despite 16.5% annual revenue growth, leaving fundamentals mixed for valuation context.

CEO DeStefano sells 472,531 shares for $17,677,608.99 in 5 transactions; -30.7% of holdings despite company full-year unprofitability

David DeStefano, President & CEO of Vertex, Inc., executed 5 separate sales totaling 472,531 shares for $17,677,608.99 across May 12–13, 2025, at prices ranging from $37.18 to $38.65 and averaging $37.41. This represents a -30.7% reduction in his holdings (from 1,539,118 to 1,066,587 shares). The sales occur while the company's most recent full fiscal year showed negative net income, despite a latest-quarter revenue of $177,062,000.00 and annual revenue growth of +16.5%. Notably, DeStefano's prior 5 trades at VERX were all well-timed at the 90-day mark (each followed by stock declines ranging from -38.5% to -43.9%), establishing a consistent pattern of selling before downturns at this specific ticker. The current stock price of $38.80 is -34.2% from the 52-week high of $58.95 and has declined -14.7% over the past 90 days, suggesting a deteriorating valuation environment relative to where he previously sold.

General Counsel sells 43.2K shares for $1.6M, reducing stake by 99.7%; stock down 22.6% in 30 days

Rowland Bryan T.R., General Counsel at Vertex, Inc., filed 2 separate sales totaling 43,228 shares for $1,555,515.19 on 2025-03-19, liquidating essentially his entire stake (99.7% reduction, leaving 132 shares post-transaction). The transactions occurred at blended average price of $35.98, while the stock has since fallen to $35.71 current price and declined 22.6% over the past 30 days and 33.3% over 90 days from a 52-week high of $58.95. His prior trades at VERX show no well-timed sells: 5 prior trades achieved 90-day returns ranging from +10.9% to +38.3%, meaning the stock rose after each sale—the pattern of a seller consistently exiting before rallies rather than before declines. Given the company's full-year unprofitability despite recent quarter revenue of $170.4M and 16.5% annual growth, context matters for interpreting a near-total departure by the top legal officer at a $941.3M market-cap firm during a sharp downtrend.

Director Gayton Bradley M buys 9,400 shares for $299,381.71 at Vertex (VERX), raising stake 24.6% amid -45.4% YTD pullback

Director Gayton Bradley M executed 2 separate purchases totaling 9,400 shares for $299,381.71 on 2025-03-04, lifting his holdings from 38,135 shares to 47,535 shares (a +24.6% increase in position size). The purchases occurred at $31.82–$31.85, a blended average of $31.85, while the stock trades -45.4% from its 52-week high of $58.95 and is down -44.2% over the past 30 days. Vertex shows strong revenue growth of +16.5% annually with $170.4M in latest quarterly revenue, but the company was unprofitable over its most recent full fiscal year despite posting $7.2M net income in the latest quarter. The significant share accumulation by a director during a steep drawdown warrants monitoring of whether the stock represents a tactical opportunity or signals confidence in turnaround execution.

10% owner Jeffrey R. Westphal's trust sells 72,000 VERX shares (5.6% of holdings) for $4,067,286.28 at $56.48–$56.52 across two days.

A 10% shareholder liquidated 72,000 shares (5.6% of prior holdings) through two separate transactions on consecutive days at prices near the 52-week high of $57.00, raising $4,067,286.28. At the same ticker, the insider's prior 5 trades show mixed timing: a recent August 2024 sale registered a strong 90-day return of +44.4%, but overall only 0 of 1 measurable same-ticker sales were well-timed. The company trades at a P/E of 49.57 while unprofitable on a full-year basis, despite recent revenue growth of +16.4% and positive quarterly net income; current price sits at 52-week highs (+0.0% from high, +6.5% in 30 days). The sale near peak valuations and elevated stock momentum warrants examination of whether this represents portfolio management activity or a broader signal about medium-term stock prospects.